Darzalex Faspro 1800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) injection Images

Generic Name: daratumumab/hyaluronidase

This medication has been identified as Darzalex Faspro 1800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) injection. It is supplied by Janssen Biotech, Inc.

Darzalex Faspro is used in the treatment of Multiple Myeloma; Amyloidosis and belongs to the drug class CD38 monoclonal antibodies. Darzalex Faspro 1800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Darzalex Faspro

Generic Name: daratumumab/hyaluronidase
Strength: 1800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) injection
Availability: Prescription only
Drug Class: CD38 monoclonal antibodies
CSA Schedule: Not a controlled drug
Labeler / Supplier: Janssen Biotech, Inc.
National Drug Code (NDC): 57894-0503